1 Automated Molecular Diagnostics Testing System Market Overview
1.1 Product Overview and Scope of Automated Molecular Diagnostics Testing System
1.2 Automated Molecular Diagnostics Testing System Segment by Type
1.2.1 Global Automated Molecular Diagnostics Testing System Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 PCR (Polymerase Chain Reaction)
1.2.3 FISH (Fluorescent In-situ Hybridization)
1.2.4 Spectral Karyotype Imaging
1.2.5 DNA Microarrays
1.3 Automated Molecular Diagnostics Testing System Segment by Application
1.3.1 Global Automated Molecular Diagnostics Testing System Sales Comparison by Application: (2022-2028)
1.3.2 Pathology Laboratories
1.3.3 Hospitals
1.3.4 Research Centers
1.3.5 Academic Institutions
1.3.6 Commercial R&D Centers
1.4 Global Automated Molecular Diagnostics Testing System Market Size Estimates and Forecasts
1.4.1 Global Automated Molecular Diagnostics Testing System Revenue 2017-2028
1.4.2 Global Automated Molecular Diagnostics Testing System Sales 2017-2028
1.4.3 Automated Molecular Diagnostics Testing System Market Size by Region: 2017 Versus 2021 Versus 2028
2 Automated Molecular Diagnostics Testing System Market Competition by Manufacturers
2.1 Global Automated Molecular Diagnostics Testing System Sales Market Share by Manufacturers (2017-2022)
2.2 Global Automated Molecular Diagnostics Testing System Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Automated Molecular Diagnostics Testing System Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Automated Molecular Diagnostics Testing System Manufacturing Sites, Area Served, Product Type
2.5 Automated Molecular Diagnostics Testing System Market Competitive Situation and Trends
2.5.1 Automated Molecular Diagnostics Testing System Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Automated Molecular Diagnostics Testing System Players Market Share by Revenue
2.5.3 Global Automated Molecular Diagnostics Testing System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Automated Molecular Diagnostics Testing System Retrospective Market Scenario by Region
3.1 Global Automated Molecular Diagnostics Testing System Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Automated Molecular Diagnostics Testing System Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Automated Molecular Diagnostics Testing System Market Facts & Figures by Country
3.3.1 North America Automated Molecular Diagnostics Testing System Sales by Country
3.3.2 North America Automated Molecular Diagnostics Testing System Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Automated Molecular Diagnostics Testing System Market Facts & Figures by Country
3.4.1 Europe Automated Molecular Diagnostics Testing System Sales by Country
3.4.2 Europe Automated Molecular Diagnostics Testing System Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Automated Molecular Diagnostics Testing System Market Facts & Figures by Region
3.5.1 Asia Pacific Automated Molecular Diagnostics Testing System Sales by Region
3.5.2 Asia Pacific Automated Molecular Diagnostics Testing System Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Automated Molecular Diagnostics Testing System Market Facts & Figures by Country
3.6.1 Latin America Automated Molecular Diagnostics Testing System Sales by Country
3.6.2 Latin America Automated Molecular Diagnostics Testing System Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Automated Molecular Diagnostics Testing System Market Facts & Figures by Country
3.7.1 Middle East and Africa Automated Molecular Diagnostics Testing System Sales by Country
3.7.2 Middle East and Africa Automated Molecular Diagnostics Testing System Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Automated Molecular Diagnostics Testing System Historic Market Analysis by Type
4.1 Global Automated Molecular Diagnostics Testing System Sales Market Share by Type (2017-2022)
4.2 Global Automated Molecular Diagnostics Testing System Revenue Market Share by Type (2017-2022)
4.3 Global Automated Molecular Diagnostics Testing System Price by Type (2017-2022)
5 Global Automated Molecular Diagnostics Testing System Historic Market Analysis by Application
5.1 Global Automated Molecular Diagnostics Testing System Sales Market Share by Application (2017-2022)
5.2 Global Automated Molecular Diagnostics Testing System Revenue Market Share by Application (2017-2022)
5.3 Global Automated Molecular Diagnostics Testing System Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Roche Holding AG
6.1.1 Roche Holding AG Corporation Information
6.1.2 Roche Holding AG Description and Business Overview
6.1.3 Roche Holding AG Automated Molecular Diagnostics Testing System Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Roche Holding AG Automated Molecular Diagnostics Testing System Product Portfolio
6.1.5 Roche Holding AG Recent Developments/Updates
6.2 Abbott Laboratories
6.2.1 Abbott Laboratories Corporation Information
6.2.2 Abbott Laboratories Description and Business Overview
6.2.3 Abbott Laboratories Automated Molecular Diagnostics Testing System Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Abbott Laboratories Automated Molecular Diagnostics Testing System Product Portfolio
6.2.5 Abbott Laboratories Recent Developments/Updates
6.3 Becton Dickenson & Company
6.3.1 Becton Dickenson & Company Corporation Information
6.3.2 Becton Dickenson & Company Description and Business Overview
6.3.3 Becton Dickenson & Company Automated Molecular Diagnostics Testing System Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Becton Dickenson & Company Automated Molecular Diagnostics Testing System Product Portfolio
6.3.5 Becton Dickenson & Company Recent Developments/Updates
6.4 Siemens Healthcare GmbH
6.4.1 Siemens Healthcare GmbH Corporation Information
6.4.2 Siemens Healthcare GmbH Description and Business Overview
6.4.3 Siemens Healthcare GmbH Automated Molecular Diagnostics Testing System Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Siemens Healthcare GmbH Automated Molecular Diagnostics Testing System Product Portfolio
6.4.5 Siemens Healthcare GmbH Recent Developments/Updates
6.5 Enigma Diagnostics Ltd
6.5.1 Enigma Diagnostics Ltd Corporation Information
6.5.2 Enigma Diagnostics Ltd Description and Business Overview
6.5.3 Enigma Diagnostics Ltd Automated Molecular Diagnostics Testing System Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Enigma Diagnostics Ltd Automated Molecular Diagnostics Testing System Product Portfolio
6.5.5 Enigma Diagnostics Ltd Recent Developments/Updates
6.6 Qiagen
6.6.1 Qiagen Corporation Information
6.6.2 Qiagen Description and Business Overview
6.6.3 Qiagen Automated Molecular Diagnostics Testing System Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Qiagen Automated Molecular Diagnostics Testing System Product Portfolio
6.6.5 Qiagen Recent Developments/Updates
6.7 Bio-Rad Laboratories
6.6.1 Bio-Rad Laboratories Corporation Information
6.6.2 Bio-Rad Laboratories Description and Business Overview
6.6.3 Bio-Rad Laboratories Automated Molecular Diagnostics Testing System Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Bio-Rad Laboratories Automated Molecular Diagnostics Testing System Product Portfolio
6.7.5 Bio-Rad Laboratories Recent Developments/Updates
6.8 Cepheid Inc.
6.8.1 Cepheid Inc. Corporation Information
6.8.2 Cepheid Inc. Description and Business Overview
6.8.3 Cepheid Inc. Automated Molecular Diagnostics Testing System Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Cepheid Inc. Automated Molecular Diagnostics Testing System Product Portfolio
6.8.5 Cepheid Inc. Recent Developments/Updates
6.9 PerkinElmer Inc.
6.9.1 PerkinElmer Inc. Corporation Information
6.9.2 PerkinElmer Inc. Description and Business Overview
6.9.3 PerkinElmer Inc. Automated Molecular Diagnostics Testing System Sales, Revenue and Gross Margin (2017-2022)
6.9.4 PerkinElmer Inc. Automated Molecular Diagnostics Testing System Product Portfolio
6.9.5 PerkinElmer Inc. Recent Developments/Updates
6.10 AutoGenomics
6.10.1 AutoGenomics Corporation Information
6.10.2 AutoGenomics Description and Business Overview
6.10.3 AutoGenomics Automated Molecular Diagnostics Testing System Sales, Revenue and Gross Margin (2017-2022)
6.10.4 AutoGenomics Automated Molecular Diagnostics Testing System Product Portfolio
6.10.5 AutoGenomics Recent Developments/Updates
6.11 ELITech Group
6.11.1 ELITech Group Corporation Information
6.11.2 ELITech Group Automated Molecular Diagnostics Testing System Description and Business Overview
6.11.3 ELITech Group Automated Molecular Diagnostics Testing System Sales, Revenue and Gross Margin (2017-2022)
6.11.4 ELITech Group Automated Molecular Diagnostics Testing System Product Portfolio
6.11.5 ELITech Group Recent Developments/Updates
7 Automated Molecular Diagnostics Testing System Manufacturing Cost Analysis
7.1 Automated Molecular Diagnostics Testing System Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Automated Molecular Diagnostics Testing System
7.4 Automated Molecular Diagnostics Testing System Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Automated Molecular Diagnostics Testing System Distributors List
8.3 Automated Molecular Diagnostics Testing System Customers
9 Automated Molecular Diagnostics Testing System Market Dynamics
9.1 Automated Molecular Diagnostics Testing System Industry Trends
9.2 Automated Molecular Diagnostics Testing System Market Drivers
9.3 Automated Molecular Diagnostics Testing System Market Challenges
9.4 Automated Molecular Diagnostics Testing System Market Restraints
10 Global Market Forecast
10.1 Automated Molecular Diagnostics Testing System Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Automated Molecular Diagnostics Testing System by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Automated Molecular Diagnostics Testing System by Type (2023-2028)
10.2 Automated Molecular Diagnostics Testing System Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Automated Molecular Diagnostics Testing System by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Automated Molecular Diagnostics Testing System by Application (2023-2028)
10.3 Automated Molecular Diagnostics Testing System Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Automated Molecular Diagnostics Testing System by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Automated Molecular Diagnostics Testing System by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
